byiShook Opinion
Jan 21, 2025 - 14:10
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025. The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business Daily.
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025.
The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere â Here's Why appeared first on Investor's Business Daily.